INTERNATIONAL PATENT: NOVARTIS AG FILES APPLICATION FOR "FACTOR B INHIBITORS FOR TREATMENT OF ANCA-ASSOCIATED VASCULITIS"

GENEVA, Aug. 25 -- NOVARTIS AG (Lichtstrasse 354056 Basel) filed a patent application (PCT/IB2025/051592) for "FACTOR B INHIBITORS FOR TREATMENT OF ANCA-ASSOCIATED VASCULITIS" on Feb 14, 2025. With publication no. WO/2025/172910, the details related to the patent application was published on Aug 21, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HANSER, Malika Amel (Novartis Pharma AGLichtstrasse 354056 Basel), JUNGE, Guido (Novartis Pharma AGLichtstrasse 354056 Basel), MEIER, Matthias (Novartis Pharma AGLichtstrasse 354056 Basel)

Abstract: Described herein are methods of treating ANCA-a...